Category Archive

Treatment (Pharmaceutical)

Supreme Court’s medicinal marijuana ruling a relief for family of child with Dravet syndrome

June 18, 2015

By Deron Hamel The Supreme Court of Canada’s landmark decision to legalize all forms of consumption of medicinal marijuana means Mandy McKnight no longer has to break the law in order to stop her young son’s seizures. Mandy’s seven-year-old son, Liam, has Dravet syndrome, a severe form of epilepsy with frequent, prolonged, drug-resistant seizures. He…

CBD study shows promise, but more trials needed

May 1, 2015

By Deron Hamel Results from an early phase clinical trial suggest that cannabidiol (CBD) may be an effective treatment for stemming the number of seizures for people living with severe, drug-resistant forms of epilepsy, however, randomized controlled trials are needed before conclusions can be drawn on the chemical compound’s effectiveness, says Dr. Elizabeth Donner. While…


April 29, 2015

Update (July 6, 2015): The acetazolamide shortage has been resolved. Acetazolamide tablets are available again from AA Pharma. The Drug Identification Number or DIN is 00545015. Please note that Acetazolam (Valeant Canada LP) is no longer available, this product has been discontinued. Drug Identification Number or DIN is 00295019.  If you need any assistance please let…